Web Results


The FDA recently gave its approval to several new drugs that are part of a new class of diabetes drugs, the SGLT2 inhibitors. All have very troubling side effects. More are awaiting approval. The first of these was Johnson & Johnson's drug canagliflozin, which is marketed in the U.S. as Invokana.
What are Invokana and Farxiga? Invokana (canagliflozin) and Farxiga ( dapagliflozin) belong to the drug class sodium-glucose co-transporter-2 (SGLT2) inhibitors. The FDA approved Invokana in March 2013 and Farxiga was approved in January 2014. They are both indicated for blood glucose (sugar) con
Compare Jardiance vs Invokana vs Farxiga cost, side effects, and dosage. These are the new diabetes type-2 treatment drugs, approved by FDA. These oral diabetes pills get rid of glucose from the bloodstream, by excreting it into the urine. The manufacturers also claim that they cause weight loss,